Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
73
PharmaCompass offers a list of Urofollitropin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Urofollitropin manufacturer or Urofollitropin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Urofollitropin manufacturer or Urofollitropin supplier.
PharmaCompass also assists you with knowing the Urofollitropin API Price utilized in the formulation of products. Urofollitropin API Price is not always fixed or binding as the Urofollitropin Price is obtained through a variety of data sources. The Urofollitropin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Urofollitropin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Urofollitropin, including repackagers and relabelers. The FDA regulates Urofollitropin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Urofollitropin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Urofollitropin supplier is an individual or a company that provides Urofollitropin active pharmaceutical ingredient (API) or Urofollitropin finished formulations upon request. The Urofollitropin suppliers may include Urofollitropin API manufacturers, exporters, distributors and traders.
click here to find a list of Urofollitropin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Urofollitropin DMF (Drug Master File) is a document detailing the whole manufacturing process of Urofollitropin active pharmaceutical ingredient (API) in detail. Different forms of Urofollitropin DMFs exist exist since differing nations have different regulations, such as Urofollitropin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Urofollitropin DMF submitted to regulatory agencies in the US is known as a USDMF. Urofollitropin USDMF includes data on Urofollitropin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Urofollitropin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Urofollitropin suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Urofollitropin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Urofollitropin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Urofollitropin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Urofollitropin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Urofollitropin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Urofollitropin suppliers with NDC on PharmaCompass.
Urofollitropin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Urofollitropin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Urofollitropin GMP manufacturer or Urofollitropin GMP API supplier for your needs.
A Urofollitropin CoA (Certificate of Analysis) is a formal document that attests to Urofollitropin's compliance with Urofollitropin specifications and serves as a tool for batch-level quality control.
Urofollitropin CoA mostly includes findings from lab analyses of a specific batch. For each Urofollitropin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Urofollitropin may be tested according to a variety of international standards, such as European Pharmacopoeia (Urofollitropin EP), Urofollitropin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Urofollitropin USP).
